{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T23:42:34Z","timestamp":1769557354297,"version":"3.49.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81700446"],"award-info":[{"award-number":["81700446"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Joint Fund of Hubei Provincial Key Laboratory of Occupational Hazard Identification and Control","award":["JF2024-K01"],"award-info":[{"award-number":["JF2024-K01"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Human Cell"],"DOI":"10.1007\/s13577-026-01352-w","type":"journal-article","created":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T09:41:09Z","timestamp":1769506869000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Hippo pathway in cardiac fibrosis: mechanisms and therapeutic prospects"],"prefix":"10.1007","volume":"39","author":[{"given":"Yuting","family":"Qiu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shanshan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiatong","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meixi","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Huo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zenan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3961-7214","authenticated-orcid":false,"given":"Lili","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,27]]},"reference":[{"key":"1352_CR1","unstructured":"Mariachiara DC, Honor B, Thomas G, Lisa H, Chodziwadziwa K, Diana VM, et al. World Heart Report 2023: Confronting the World\u2019s Number One Killer. World Heart Federation. 2023."},{"issue":"11","key":"1352_CR2","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1093\/eurjpc\/zwae281","volume":"32","author":"B Chong","year":"2025","unstructured":"Chong B, Jayabaskaran J, Jauhari SM, Chan SP, Goh R, Kueh MTW, et al. Global burden of cardiovascular diseases: projections from 2025 to 2050. Eur J Prev Cardiol. 2025;32(11):1001\u201315. https:\/\/doi.org\/10.1093\/eurjpc\/zwae281.","journal-title":"Eur J Prev Cardiol"},{"issue":"12","key":"1352_CR3","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1097\/hjh.0000000000001853","volume":"36","author":"S Korkmaz-Ic\u00f6z","year":"2018","unstructured":"Korkmaz-Ic\u00f6z S, Brlecic P, Ruppert M, Radovits T, Karck M, Szab\u00f3 G. Mechanical pressure unloading therapy reverses thoracic aortic structural and functional changes in a hypertensive rat model. J Hypertens. 2018;36(12):2350\u201361. https:\/\/doi.org\/10.1097\/hjh.0000000000001853.","journal-title":"J Hypertens"},{"issue":"15","key":"1352_CR4","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1016\/j.jacc.2018.02.021","volume":"71","author":"A Gonz\u00e1lez","year":"2018","unstructured":"Gonz\u00e1lez A, Schelbert EB, D\u00edez J, Butler J. Myocardial interstitial fibrosis in heart failure: biological and translational perspectives. J Am Coll Cardiol. 2018;71(15):1696\u2013706. https:\/\/doi.org\/10.1016\/j.jacc.2018.02.021.","journal-title":"J Am Coll Cardiol"},{"issue":"27","key":"1352_CR5","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1093\/eurheartj\/ehac223","volume":"43","author":"S Frantz","year":"2022","unstructured":"Frantz S, Hundertmark MJ, Schulz-Menger J, Bengel FM, Bauersachs J. Left ventricular remodelling post-myocardial infarction: pathophysiology, imaging, and novel therapies. Eur Heart J. 2022;43(27):2549\u201361. https:\/\/doi.org\/10.1093\/eurheartj\/ehac223.","journal-title":"Eur Heart J"},{"key":"1352_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2021.113904","volume":"176","author":"I Tuleta","year":"2021","unstructured":"Tuleta I, Frangogiannis NG. Fibrosis of the diabetic heart: clinical significance, molecular mechanisms, and therapeutic opportunities. Adv Drug Deliv Rev. 2021;176:113904. https:\/\/doi.org\/10.1016\/j.addr.2021.113904.","journal-title":"Adv Drug Deliv Rev"},{"key":"1352_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.matbio.2024.08.008","volume":"134","author":"IG Lunde","year":"2024","unstructured":"Lunde IG, Rypdal KB, Van Linthout S, Diez J, Gonz\u00e1lez A. Myocardial fibrosis from the perspective of the extracellular matrix: mechanisms to clinical impact. Matrix Biol. 2024;134:1\u201322. https:\/\/doi.org\/10.1016\/j.matbio.2024.08.008.","journal-title":"Matrix Biol"},{"key":"1352_CR8","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.addr.2021.03.021","volume":"173","author":"M Liu","year":"2021","unstructured":"Liu M, de L\u00f3pez Juan Abad B, Cheng K. Cardiac fibrosis: myofibroblast-mediated pathological regulation and drug delivery strategies. Adv Drug Deliv Rev. 2021;173:504\u201319. https:\/\/doi.org\/10.1016\/j.addr.2021.03.021.","journal-title":"Adv Drug Deliv Rev"},{"key":"1352_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24021756","author":"A Bertaud","year":"2023","unstructured":"Bertaud A, Joshkon A, Heim X, Bachelier R, Bardin N, Leroyer AS, et al. Signaling pathways and potential therapeutic strategies in cardiac fibrosis. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms24021756.","journal-title":"Int J Mol Sci"},{"issue":"11","key":"1352_CR10","doi-asserted-by":"publisher","first-page":"4045","DOI":"10.1007\/s11010-021-04219-w","volume":"476","author":"W Qin","year":"2021","unstructured":"Qin W, Cao L, Massey IY. Role of PI3K\/Akt signaling pathway in cardiac fibrosis. Mol Cell Biochem. 2021;476(11):4045\u201359. https:\/\/doi.org\/10.1007\/s11010-021-04219-w.","journal-title":"Mol Cell Biochem"},{"issue":"5","key":"1352_CR11","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1172\/jci98215","volume":"128","author":"X Fu","year":"2018","unstructured":"Fu X, Khalil H, Kanisicak O, Boyer JG, Vagnozzi RJ, Maliken BD, et al. Specialized fibroblast differentiated states underlie scar formation in the infarcted mouse heart. J Clin Invest. 2018;128(5):2127\u201343. https:\/\/doi.org\/10.1172\/jci98215.","journal-title":"J Clin Invest"},{"issue":"12","key":"1352_CR12","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.7150\/ijbs.28103","volume":"14","author":"ZG Ma","year":"2018","unstructured":"Ma ZG, Yuan YP, Wu HM, Zhang X, Tang QZ. Cardiac fibrosis: new insights into the pathogenesis. Int J Biol Sci. 2018;14(12):1645\u201357. https:\/\/doi.org\/10.7150\/ijbs.28103.","journal-title":"Int J Biol Sci"},{"issue":"11","key":"1352_CR13","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/s41569-018-0063-3","volume":"15","author":"J Wang","year":"2018","unstructured":"Wang J, Liu S, Heallen T, Martin JF. The Hippo pathway in the heart: pivotal roles in development, disease, and regeneration. Nat Rev Cardiol. 2018;15(11):672\u201384. https:\/\/doi.org\/10.1038\/s41569-018-0063-3.","journal-title":"Nat Rev Cardiol"},{"issue":"1","key":"1352_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-022-01191-9","volume":"7","author":"M Fu","year":"2022","unstructured":"Fu M, Hu Y, Lan T, Guan KL, Luo T, Luo M. The hippo signalling pathway and its implications in human health and diseases. Signal Transduct Target Ther. 2022;7(1):376. https:\/\/doi.org\/10.1038\/s41392-022-01191-9.","journal-title":"Signal Transduct Target Ther"},{"issue":"19","key":"1352_CR15","doi-asserted-by":"publisher","first-page":"5798","DOI":"10.1111\/febs.16091","volume":"289","author":"H Kwon","year":"2022","unstructured":"Kwon H, Kim J, Jho EH. Role of the hippo pathway and mechanisms for controlling cellular localization of YAP\/TAZ. FEBS J. 2022;289(19):5798\u2013818. https:\/\/doi.org\/10.1111\/febs.16091.","journal-title":"FEBS J"},{"issue":"48","key":"1352_CR16","doi-asserted-by":"publisher","first-page":"37159","DOI":"10.1074\/jbc.M110.152942","volume":"285","author":"CY Liu","year":"2010","unstructured":"Liu CY, Zha ZY, Zhou X, Zhang H, Huang W, Zhao D, et al. The hippo tumor pathway promotes TAZ degradation by phosphorylating a phosphodegron and recruiting the SCF{beta}-TrCP E3 ligase. J Biol Chem. 2010;285(48):37159\u201369. https:\/\/doi.org\/10.1074\/jbc.M110.152942.","journal-title":"J Biol Chem"},{"issue":"1","key":"1352_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1101\/gad.274027.115","volume":"30","author":"Z Meng","year":"2016","unstructured":"Meng Z, Moroishi T, Guan KL. Mechanisms of hippo pathway regulation. Genes Dev. 2016;30(1):1\u201317. https:\/\/doi.org\/10.1101\/gad.274027.115.","journal-title":"Genes Dev"},{"issue":"2","key":"1352_CR18","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.cmet.2018.07.010","volume":"28","author":"JH Koo","year":"2018","unstructured":"Koo JH, Guan KL. Interplay between YAP\/TAZ and metabolism. Cell Metab. 2018;28(2):196\u2013206. https:\/\/doi.org\/10.1016\/j.cmet.2018.07.010.","journal-title":"Cell Metab"},{"issue":"7","key":"1352_CR19","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1093\/cvr\/cvab205","volume":"118","author":"MM Mia","year":"2022","unstructured":"Mia MM, Cibi DM, Ghani S, Singh A, Tee N, Sivakumar V, et al. Loss of yap\/taz in cardiac fibroblasts attenuates adverse remodelling and improves cardiac function. Cardiovasc Res. 2022;118(7):1785\u2013804. https:\/\/doi.org\/10.1093\/cvr\/cvab205.","journal-title":"Cardiovasc Res"},{"issue":"9","key":"1352_CR20","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/j.jacbts.2020.07.009","volume":"5","author":"J Francisco","year":"2020","unstructured":"Francisco J, Zhang Y, Jeong JI, Mizushima W, Ikeda S, Ivessa A, et al. Blockade of fibroblast YAP attenuates cardiac fibrosis and dysfunction through MRTF-A inhibition. JACC: Basic Translat Sci. 2020;5(9):931\u201345. https:\/\/doi.org\/10.1016\/j.jacbts.2020.07.009.","journal-title":"JACC: Basic Translat Sci"},{"issue":"6","key":"1352_CR21","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1093\/cvr\/cvaa324","volume":"117","author":"NG Frangogiannis","year":"2021","unstructured":"Frangogiannis NG. Cardiac fibrosis. Cardiovasc Res. 2021;117(6):1450\u201388. https:\/\/doi.org\/10.1093\/cvr\/cvaa324.","journal-title":"Cardiovasc Res"},{"key":"1352_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/cells10092412","author":"P Umbarkar","year":"2021","unstructured":"Umbarkar P, Ejantkar S, Tousif S, Lal H. Mechanisms of fibroblast activation and myocardial fibrosis: lessons learned from FB-specific conditional mouse models. Cells. 2021. https:\/\/doi.org\/10.3390\/cells10092412.","journal-title":"Cells"},{"key":"1352_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12260","volume":"7","author":"O Kanisicak","year":"2016","unstructured":"Kanisicak O, Khalil H, Ivey MJ, Karch J, Maliken BD, Correll RN, et al. Genetic lineage tracing defines myofibroblast origin and function in the injured heart. Nat Commun. 2016;7:12260. https:\/\/doi.org\/10.1038\/ncomms12260.","journal-title":"Nat Commun"},{"issue":"12","key":"1352_CR24","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1161\/circresaha.116.308643","volume":"118","author":"H Kaur","year":"2016","unstructured":"Kaur H, Takefuji M, Ngai CY, Carvalho J, Bayer J, Wietelmann A, et al. Targeted ablation of periostin-expressing activated fibroblasts prevents adverse cardiac remodeling in mice. Circ Res. 2016;118(12):1906\u201317. https:\/\/doi.org\/10.1161\/circresaha.116.308643.","journal-title":"Circ Res"},{"issue":"2","key":"1352_CR25","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.devcel.2018.03.019","volume":"45","author":"Y Xiao","year":"2018","unstructured":"Xiao Y, Hill MC, Zhang M, Martin TJ, Morikawa Y, Wang S, et al. Hippo signaling plays an essential role in cell state transitions during cardiac fibroblast development. Dev Cell. 2018;45(2):153\u201369. https:\/\/doi.org\/10.1016\/j.devcel.2018.03.019.","journal-title":"Dev Cell"},{"issue":"21-22","key":"1352_CR26","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1101\/gad.329763.119","volume":"33","author":"Y Xiao","year":"2019","unstructured":"Xiao Y, Hill MC, Li L, Deshmukh V, Martin TJ, Wang J, et al. Hippo pathway deletion in adult resting cardiac fibroblasts initiates a cell state transition with spontaneous and self-sustaining fibrosis. Genes Dev. 2019;33(21\u201322):1491\u2013505. https:\/\/doi.org\/10.1101\/gad.329763.119.","journal-title":"Genes Dev"},{"issue":"1","key":"1352_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-89989-5","volume":"11","author":"J Francisco","year":"2021","unstructured":"Francisco J, Zhang Y, Nakada Y, Jeong JI, Huang CY, Ivessa A, et al. AAV-mediated YAP expression in cardiac fibroblasts promotes inflammation and increases fibrosis. Sci Rep. 2021;11(1):10553. https:\/\/doi.org\/10.1038\/s41598-021-89989-5.","journal-title":"Sci Rep"},{"issue":"1","key":"1352_CR28","doi-asserted-by":"publisher","DOI":"10.1007\/s00395-021-00865-9","volume":"116","author":"NM Landry","year":"2021","unstructured":"Landry NM, Rattan SG, Filomeno KL, Meier TW, Meier SC, Foran SJ, et al. SKI activates the Hippo pathway via LIMD1 to inhibit cardiac fibroblast activation. Basic Res Cardiol. 2021;116(1):25. https:\/\/doi.org\/10.1007\/s00395-021-00865-9.","journal-title":"Basic Res Cardiol"},{"issue":"1","key":"1352_CR29","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s12265-020-10006-7","volume":"14","author":"B Chen","year":"2021","unstructured":"Chen B, Frangogiannis NG. Chemokines in myocardial infarction. J Cardiovasc Transl Res. 2021;14(1):35\u201352. https:\/\/doi.org\/10.1007\/s12265-020-10006-7.","journal-title":"J Cardiovasc Transl Res"},{"issue":"20","key":"1352_CR30","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1161\/circulationaha.119.044914","volume":"141","author":"TC Kuhn","year":"2020","unstructured":"Kuhn TC, Knobel J, Burkert-Rettenmaier S, Li X, Meyer IS, Jungmann A, et al. Secretome analysis of cardiomyocytes identifies PCSK6 (proprotein convertase subtilisin\/kexin type 6) as a novel player in cardiac remodeling after myocardial infarction. Circulation. 2020;141(20):1628\u201344. https:\/\/doi.org\/10.1161\/circulationaha.119.044914.","journal-title":"Circulation"},{"issue":"3","key":"1352_CR31","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1161\/hypertensionaha.118.11874","volume":"73","author":"E Mart\u00ednez-Mart\u00ednez","year":"2019","unstructured":"Mart\u00ednez-Mart\u00ednez E, Brugnolaro C, Ibarrola J, Ravassa S, Buonafine M, L\u00f3pez B, et al. CT-1 (cardiotrophin-1)-Gal-3 (galectin-3) axis in cardiac fibrosis and inflammation. Hypertension. 2019;73(3):602\u201311. https:\/\/doi.org\/10.1161\/hypertensionaha.118.11874.","journal-title":"Hypertension"},{"issue":"6028","key":"1352_CR32","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1126\/science.1199010","volume":"332","author":"T Heallen","year":"2011","unstructured":"Heallen T, Zhang M, Wang J, Bonilla-Claudio M, Klysik E, Johnson RL, et al. Hippo pathway inhibits Wnt signaling to restrain cardiomyocyte proliferation and heart size. Science. 2011;332(6028):458\u201361. https:\/\/doi.org\/10.1126\/science.1199010.","journal-title":"Science"},{"issue":"7675","key":"1352_CR33","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1038\/nature24045","volume":"550","author":"JP Leach","year":"2017","unstructured":"Leach JP, Heallen T, Zhang M, Rahmani M, Morikawa Y, Hill MC, et al. Hippo pathway deficiency reverses systolic heart failure after infarction. Nature. 2017;550(7675):260\u20134. https:\/\/doi.org\/10.1038\/nature24045.","journal-title":"Nature"},{"issue":"10","key":"1352_CR34","doi-asserted-by":"publisher","first-page":"3555","DOI":"10.1172\/jci43569","volume":"120","author":"DP Del Re","year":"2010","unstructured":"Del Re DP, Matsuda T, Zhai P, Gao S, Clark GJ, Van Der Weyden L, et al. Proapoptotic Rassf1A\/Mst1 signaling in cardiac fibroblasts is protective against pressure overload in mice. J Clin Invest. 2010;120(10):3555\u201367. https:\/\/doi.org\/10.1172\/jci43569.","journal-title":"J Clin Invest"},{"issue":"35","key":"1352_CR35","doi-asserted-by":"publisher","first-page":"24275","DOI":"10.1074\/jbc.M114.562405","volume":"289","author":"M Zi","year":"2014","unstructured":"Zi M, Maqsood A, Prehar S, Mohamed TM, Abou-Leisa R, Robertson A, et al. The mammalian Ste20-like kinase 2 (Mst2) modulates stress-induced cardiac hypertrophy. J Biol Chem. 2014;289(35):24275\u201388. https:\/\/doi.org\/10.1074\/jbc.M114.562405.","journal-title":"J Biol Chem"},{"issue":"2","key":"1352_CR36","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1002\/path.4133","volume":"229","author":"A Mantovani","year":"2013","unstructured":"Mantovani A, Biswas SK, Galdiero MR, Sica A, Locati M. Macrophage plasticity and polarization in tissue repair and remodelling. J Pathol. 2013;229(2):176\u201385. https:\/\/doi.org\/10.1002\/path.4133.","journal-title":"J Pathol"},{"issue":"12","key":"1352_CR37","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1038\/nri2448","volume":"8","author":"DM Mosser","year":"2008","unstructured":"Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nat Rev Immunol. 2008;8(12):958\u201369. https:\/\/doi.org\/10.1038\/nri2448.","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"1352_CR38","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.immuni.2010.05.007","volume":"32","author":"S Gordon","year":"2010","unstructured":"Gordon S, Martinez FO. Alternative activation of macrophages: mechanism and functions. Immunity. 2010;32(5):593\u2013604. https:\/\/doi.org\/10.1016\/j.immuni.2010.05.007.","journal-title":"Immunity"},{"issue":"1","key":"1352_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-017-0322-3","volume":"24","author":"A Gombozhapova","year":"2017","unstructured":"Gombozhapova A, Rogovskaya Y, Shurupov V, Rebenkova M, Kzhyshkowska J, Popov SV, et al. Macrophage activation and polarization in post-infarction cardiac remodeling. J Biomed Sci. 2017;24(1):13. https:\/\/doi.org\/10.1186\/s12929-017-0322-3.","journal-title":"J Biomed Sci"},{"issue":"12","key":"1352_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3000941","volume":"18","author":"MM Mia","year":"2020","unstructured":"Mia MM, Cibi DM, Abdul Ghani SAB, Song W, Tee N, Ghosh S, et al. YAP\/TAZ deficiency reprograms macrophage phenotype and improves infarct healing and cardiac function after myocardial infarction. PLoS Biol. 2020;18(12):e3000941. https:\/\/doi.org\/10.1371\/journal.pbio.3000941.","journal-title":"PLoS Biol"},{"issue":"3","key":"1352_CR41","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1172\/jci88759","volume":"127","author":"V Ramjee","year":"2017","unstructured":"Ramjee V, Li D, Manderfield LJ, Liu F, Engleka KA, Aghajanian H, et al. Epicardial YAP\/TAZ orchestrate an immunosuppressive response following myocardial infarction. J Clin Invest. 2017;127(3):899\u2013911. https:\/\/doi.org\/10.1172\/jci88759.","journal-title":"J Clin Invest"},{"key":"1352_CR42","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.matbio.2018.01.013","volume":"68-69","author":"L Li","year":"2018","unstructured":"Li L, Zhao Q, Kong W. Extracellular matrix remodeling and cardiac fibrosis. Matrix Biol. 2018;68\u201369:490\u2013506. https:\/\/doi.org\/10.1016\/j.matbio.2018.01.013.","journal-title":"Matrix Biol"},{"issue":"8","key":"1352_CR43","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/s41569-018-0022-z","volume":"15","author":"ML Lindsey","year":"2018","unstructured":"Lindsey ML. Assigning matrix metalloproteinase roles in ischaemic cardiac remodelling. Nat Rev Cardiol. 2018;15(8):471\u20139. https:\/\/doi.org\/10.1038\/s41569-018-0022-z.","journal-title":"Nat Rev Cardiol"},{"issue":"1","key":"1352_CR44","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1161\/circresaha.119.311148","volume":"125","author":"NG Frangogiannis","year":"2019","unstructured":"Frangogiannis NG. The extracellular matrix in ischemic and nonischemic heart failure. Circ Res. 2019;125(1):117\u201346. https:\/\/doi.org\/10.1161\/circresaha.119.311148.","journal-title":"Circ Res"},{"issue":"6","key":"1352_CR45","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/nmat3945","volume":"13","author":"Y Sun","year":"2014","unstructured":"Sun Y, Yong KM, Villa-Diaz LG, Zhang X, Chen W, Philson R, et al. Hippo\/YAP-mediated rigidity-dependent motor neuron differentiation of human pluripotent stem cells. Nat Mater. 2014;13(6):599\u2013604. https:\/\/doi.org\/10.1038\/nmat3945.","journal-title":"Nat Mater"},{"issue":"6","key":"1352_CR46","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/s41569-019-0155-8","volume":"16","author":"JJ Saucerman","year":"2019","unstructured":"Saucerman JJ, Tan PM, Buchholz KS, McCulloch AD, Omens JH. Mechanical regulation of gene expression in cardiac myocytes and fibroblasts. Nat Rev Cardiol. 2019;16(6):361\u201378. https:\/\/doi.org\/10.1038\/s41569-019-0155-8.","journal-title":"Nat Rev Cardiol"},{"issue":"11","key":"1352_CR47","doi-asserted-by":"publisher","first-page":"8345","DOI":"10.1002\/jcp.29678","volume":"235","author":"L Niu","year":"2020","unstructured":"Niu L, Jia Y, Wu M, Liu H, Feng Y, Hu Y, et al. Matrix stiffness controls cardiac fibroblast activation through regulating YAP via AT(1) R. J Cell Physiol. 2020;235(11):8345\u201357. https:\/\/doi.org\/10.1002\/jcp.29678.","journal-title":"J Cell Physiol"},{"issue":"7350","key":"1352_CR48","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/nature10137","volume":"474","author":"S Dupont","year":"2011","unstructured":"Dupont S, Morsut L, Aragona M, Enzo E, Giulitti S, Cordenonsi M, et al. Role of YAP\/TAZ in mechanotransduction. Nature. 2011;474(7350):179\u201383. https:\/\/doi.org\/10.1038\/nature10137.","journal-title":"Nature"},{"issue":"7720","key":"1352_CR49","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/s41586-018-0444-0","volume":"560","author":"Z Meng","year":"2018","unstructured":"Meng Z, Qiu Y, Lin KC, Kumar A, Placone JK, Fang C, et al. RAP2 mediates mechanoresponses of the Hippo pathway. Nature. 2018;560(7720):655\u201360. https:\/\/doi.org\/10.1038\/s41586-018-0444-0.","journal-title":"Nature"},{"issue":"8","key":"1352_CR50","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/ncb2537","volume":"14","author":"M Gloerich","year":"2012","unstructured":"Gloerich M, ten Klooster JP, Vliem MJ, Koorman T, Zwartkruis FJ, Clevers H, et al. Rap2A links intestinal cell polarity to brush border formation. Nat Cell Biol. 2012;14(8):793\u2013801. https:\/\/doi.org\/10.1038\/ncb2537.","journal-title":"Nat Cell Biol"},{"issue":"1-2","key":"1352_CR51","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1080\/14728222.2024.2316735","volume":"28","author":"NG Frangogiannis","year":"2024","unstructured":"Frangogiannis NG. TGF-\u03b2 as a therapeutic target in the infarcted and failing heart: cellular mechanisms, challenges, and opportunities. Expert Opin Ther Targets. 2024;28(1\u20132):45\u201356. https:\/\/doi.org\/10.1080\/14728222.2024.2316735.","journal-title":"Expert Opin Ther Targets"},{"key":"1352_CR52","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.actbio.2022.08.063","volume":"152","author":"S Ragazzini","year":"2022","unstructured":"Ragazzini S, Scocozza F, Bernava G, Auricchio F, Colombo GI, Barbuto M, et al. Mechanosensor YAP cooperates with TGF-\u03b21 signaling to promote myofibroblast activation and matrix stiffening in a 3D model of human cardiac fibrosis. Acta Biomater. 2022;152:300\u201312. https:\/\/doi.org\/10.1016\/j.actbio.2022.08.063.","journal-title":"Acta Biomater"},{"key":"1352_CR53","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21197412","author":"R Romero-Becerra","year":"2020","unstructured":"Romero-Becerra R, Santamans AM, Folgueira C, Sabio G. P38 MAPK pathway in the heart: new insights in health and disease. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21197412.","journal-title":"Int J Mol Sci"},{"issue":"10","key":"1352_CR54","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1161\/circresaha.119.316162","volume":"127","author":"D Bugg","year":"2020","unstructured":"Bugg D, Bretherton R, Kim P, Olszewski E, Nagle A, Schumacher AE, et al. Infarct collagen topography regulates fibroblast fate via p38-Yes-Associated protein transcriptional enhanced associate domain signals. Circ Res. 2020;127(10):1306\u201322. https:\/\/doi.org\/10.1161\/circresaha.119.316162.","journal-title":"Circ Res"},{"issue":"9","key":"1352_CR55","doi-asserted-by":"publisher","first-page":"7018","DOI":"10.1074\/jbc.C110.212621","volume":"286","author":"SW Chan","year":"2011","unstructured":"Chan SW, Lim CJ, Chong YF, Pobbati AV, Huang C, Hong W. Hippo pathway-independent restriction of TAZ and YAP by angiomotin. J Biol Chem. 2011;286(9):7018\u201326. https:\/\/doi.org\/10.1074\/jbc.C110.212621.","journal-title":"J Biol Chem"},{"issue":"7","key":"1352_CR56","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1002\/bies.201600037","volume":"38","author":"A Elbediwy","year":"2016","unstructured":"Elbediwy A, Vincent-Mistiaen ZI, Thompson BJ. YAP and TAZ in epithelial stem cells: a sensor for cell polarity, mechanical forces and tissue damage. BioEssays. 2016;38(7):644\u201353. https:\/\/doi.org\/10.1002\/bies.201600037.","journal-title":"BioEssays"},{"issue":"7","key":"1352_CR57","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.cub.2010.02.035","volume":"20","author":"M Das Thakur","year":"2010","unstructured":"Das Thakur M, Feng Y, Jagannathan R, Seppa MJ, Skeath JB, Longmore GD. Ajuba LIM proteins are negative regulators of the Hippo signaling pathway. Curr Biol. 2010;20(7):657\u201362. https:\/\/doi.org\/10.1016\/j.cub.2010.02.035.","journal-title":"Curr Biol"},{"key":"1352_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.mito.2024.101941","volume":"78","author":"XJ Du","year":"2024","unstructured":"Du XJ, She G, Wu W, Deng XL. Coupling of \u03b2-adrenergic and Hippo pathway signaling: implications for heart failure pathophysiology and metabolic therapy. Mitochondrion. 2024;78:101941. https:\/\/doi.org\/10.1016\/j.mito.2024.101941.","journal-title":"Mitochondrion"},{"key":"1352_CR59","unstructured":"Yujia H, YY, Chengli Z, Zhongyong J, Quanwei L. Effect of wogonin on myocardial fibrosis in rats with chronic heart failure by regulating Hippo\/YAP signaling pathway. Chin J Integr Med Cardio\/Cerebrovascular Dis. 2024."},{"issue":"8","key":"1352_CR60","first-page":"874","volume":"43","author":"Y-n Gu","year":"2022","unstructured":"Gu Y-n, Song W, Xia K-J, Xie C-y. Effects of salidroside on myocardial inflammatory cytokines and Hippo signaling pathway-related proteins in diabetes mellitus rats. J Med Coll PLA. 2022;43(8):874\u201380.","journal-title":"J Med Coll PLA"},{"issue":"12","key":"1352_CR61","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1101\/gad.192856.112","volume":"26","author":"Y Liu-Chittenden","year":"2012","unstructured":"Liu-Chittenden Y, Huang B, Shim JS, Chen Q, Lee SJ, Anders RA, et al. Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP. Genes Dev. 2012;26(12):1300\u20135. https:\/\/doi.org\/10.1101\/gad.192856.112.","journal-title":"Genes Dev"},{"issue":"3","key":"1352_CR62","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1161\/circresaha.121.319373","volume":"131","author":"G Garoffolo","year":"2022","unstructured":"Garoffolo G, Casaburo M, Amadeo F, Salvi M, Bernava G, Piacentini L, et al. Reduction of cardiac fibrosis by interference with YAP-dependent transactivation. Circ Res. 2022;131(3):239\u201357. https:\/\/doi.org\/10.1161\/circresaha.121.319373.","journal-title":"Circ Res"},{"issue":"4","key":"1352_CR63","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1165\/rcmb.2019-0296OC","volume":"62","author":"DM Santos","year":"2020","unstructured":"Santos DM, Pantano L, Pronzati G, Grasberger P, Probst CK, Black KE, et al. Screening for YAP inhibitors identifies statins as modulators of fibrosis. Am J Respir Cell Mol Biol. 2020;62(4):479\u201392. https:\/\/doi.org\/10.1165\/rcmb.2019-0296OC.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"9","key":"1352_CR64","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1038\/s41418-018-0250-0","volume":"26","author":"Y Chen","year":"2019","unstructured":"Chen Y, Zhao X, Sun J, Su W, Zhang L, Li Y, et al. YAP1\/Twist promotes fibroblast activation and lung fibrosis that conferred by miR-15a loss in IPF. Cell Death Differ. 2019;26(9):1832\u201344. https:\/\/doi.org\/10.1038\/s41418-018-0250-0.","journal-title":"Cell Death Differ"},{"key":"1352_CR65","doi-asserted-by":"publisher","unstructured":"Junqing W, Huifan Y, Linsheng H, LuJie W, Jingyu L, Lu Y, Fei L. Hypericin ameliorates renal tubulointerstitial fibrosis via inhibiting YAP. Acta Med Univ Sci Technol Huazhong. 2025;54(2):190\u20137. https:\/\/doi.org\/10.3870\/j.issn.1672-0741.24.11.033.","DOI":"10.3870\/j.issn.1672-0741.24.11.033"},{"key":"1352_CR66","unstructured":"JunYi Z. Taurine-deoxycholic acid inhibits liver stellate cell activation through the Hippo\/YAP pathway to alleviate liver fibrosis. Huazhong Agricultural University; 2023."},{"issue":"352","key":"1352_CR67","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaf2304","volume":"8","author":"F Fan","year":"2016","unstructured":"Fan F, He Z, Kong LL, Chen Q, Yuan Q, Zhang S, et al. Pharmacological targeting of kinases MST1 and MST2 augments tissue repair and regeneration. Sci Transl Med. 2016;8(352):352ra108. https:\/\/doi.org\/10.1126\/scitranslmed.aaf2304.","journal-title":"Sci Transl Med"},{"issue":"3","key":"1352_CR68","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.7150\/ijbs.87057","volume":"20","author":"Y An","year":"2024","unstructured":"An Y, Tan S, Zhang P, Yang J, Wang K, Zheng R, et al. Inactivation of MST1\/2 controls macrophage polarization to affect macrophage-related disease via YAP and non-YAP mechanisms. Int J Biol Sci. 2024;20(3):1004\u201323. https:\/\/doi.org\/10.7150\/ijbs.87057.","journal-title":"Int J Biol Sci"},{"issue":"22","key":"1352_CR69","doi-asserted-by":"publisher","first-page":"55","DOI":"10.7619\/jcmp.202419","volume":"28","author":"G Abudukaha","year":"2024","unstructured":"Abudukaha G, Yatan L, Fan Y. Regulation of atorvastatin on the Hippo-YAP signaling pathway in rats with chronic heart failure and its impact on ventricular remodeling. J Clin Med Pract. 2024;28(22):55\u201361. https:\/\/doi.org\/10.7619\/jcmp.202419.","journal-title":"J Clin Med Pract"},{"key":"1352_CR70","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10051032","author":"YJ Heo","year":"2022","unstructured":"Heo YJ, Lee N, Choi SE, Jeon JY, Han SJ, Kim DJ, et al. Empagliflozin reduces the progression of hepatic fibrosis in a mouse model and inhibits the activation of hepatic stellate cells via the Hippo signalling pathway. Biomedicines. 2022. https:\/\/doi.org\/10.3390\/biomedicines10051032.","journal-title":"Biomedicines"}],"container-title":["Human Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-026-01352-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13577-026-01352-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-026-01352-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T09:41:15Z","timestamp":1769506875000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13577-026-01352-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,27]]},"references-count":70,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["1352"],"URL":"https:\/\/doi.org\/10.1007\/s13577-026-01352-w","relation":{},"ISSN":["1749-0774"],"issn-type":[{"value":"1749-0774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,27]]},"assertion":[{"value":"15 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflicts of interest to declare that are relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"39"}}